Luis Molina
Autonomous University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Luis Molina.
Medicine and Science in Sports and Exercise | 2000
Roberto Elosua; Montserrat Garcia; Amparo Aguilar; Luis Molina; Mar A-Isabel Covas; Jaume Marrugat
PURPOSE Regular physical activity (PA) is associated with lower risk for several chronic diseases. It is important to validate PA measurement instruments in different populations. The objective was to validate the Minnesota leisure time PA questionnaire among Spanish women. METHODS A cross-sectional study with quota sampling was designed. Two PA groups (active, expending less than 301 MET-min x d(-1) in PA, and very active, expending more than 300 MET-min x d(-1)) and two age groups (18-40 and 41-60 yr) were defined. The Minnesota questionnaire was administered to obtain total energy expenditure in leisure time PA (EEPAtotal) and classified according to the intensity of the different types of PA (EEPAheavy, EEPAmoderate, and EEPAlight). The 250 women recruited performed an exercise test to assess fitness. RESULTS Spearman correlation coefficients among EEPAtotal, EEPAheavy, EEPAmoderate, EEPAlight, and fitness were 0.39, 0.51, 0.13, and 0.02, respectively. Multiple linear regression model adjusted by the different EEPAs and age accounted for 46% of fitness variability. Besides age, only EEPAmoderate and EEPAheavy were associated with fitness. CONCLUSION The Spanish version of the Minnesota questionnaire is a valid instrument for measuring leisure time PA performed in the last year in Spanish women aged 18-60 yr. Moderate and heavy physical activity are adequately assessed whereas light physical activity practice assessment may be questionable.
American Journal of Cardiology | 1999
Luis Molina; Roberto Elosua; Jaume Marrugat; Silvia Pons
The relation between maximum systolic blood pressure (BP) during exercise and left ventricular (LV) mass is controversial. Physical activity also induces LV mass increase. The objective was to assess the relation between BP response to exercise and LV mass in normotensive men, taking into account physical activity practice. A cross-sectional study was performed. Three hundred eighteen healthy normotensive men, aged between 20 and 60 years, participated in this study. The Minnesota questionnaire was used to assess physical activity practice. An echocardiogram and a maximum exercise test were performed. LV mass was calculated and indexed to body surface area. LV hypertrophy was defined as a ventricular mass index > or =134 g/m2. BP was measured at the moment of maximum effort. Hypertensive response was considered when BP was > or =210 mm Hg. In the multiple linear regression model, maximum systolic BP was associated with LV mass index and correlation coefficient was 0.27 (SE 0.07). Physical activity practice and age were also associated with LV mass. An association between hypertensive response to exercise and LV hypertrophy was observed (odds ratio 3.16). Thus, BP response to exercise is associated with LV mass and men with systolic BP response > or =210 mm Hg present a 3-times higher risk of LV hypertrophy than those not reaching this limit. Physical activity practice is related to LV mass, but not to LV hypertrophy.
Revista Espanola De Cardiologia | 2012
José M. Verdú; Josep Comin-Colet; Mar Domingo; Josep Lupón; Miguel Ángel Gómez; Luis Molina; Jose M. Casacuberta; Miguel A. Muñoz; Amparo Mena; Jordi Bruguera-Cortada
INTRODUCTION AND OBJECTIVES Measurement of natriuretic peptides may be recommended prior to echocardiography in patients with suspected heart failure. Cut-off point for heart failure diagnosis in primary care is not well established. We aimed to assess the optimal diagnostic cut-off value of N-terminal pro-B-type natriuretic peptide on a community population attended in primary care. METHODS Prospective diagnostic accuracy study of a rapid point-of-care N-terminal pro-B-type natriuretic peptide test in a primary healthcare centre. Consecutive patients referred by their general practitioners to echocardiography due to suspected heart failure were included. Clinical history and physical examination based on Framingham criteria, electrocardiogram, chest X-ray, N-terminal pro-B-type natriuretic peptide measurement and echocardiogram were performed. Heart failure diagnosis was made by a cardiologist blinded to N-terminal pro-B-type natriuretic peptide value, using the European Society of Cardiology diagnosis criteria (clinical and echocardiographic data). RESULTS Of 220 patients evaluated (65.5% women; median 74 years [interquartile range 67-81]). Heart failure diagnosis was confirmed in 52 patients (23.6%), 16 (30.8%) with left ventricular ejection fraction <50% (39.6 [5.1]%). Median values of N-terminal pro-B-type natriuretic peptide were 715 pg/mL [interquartile range 510.5-1575] and 77.5 pg/mL [interquartile range 58-179.75] for patients with and without heart failure respectively. The best cut-off point was 280 pg/mL, with a receiver operating characteristic curve of 0.94 (95% confidence interval, 0.91-0.97). Six patients with heart failure diagnosis (11.5%) had N-terminal pro-B-type natriuretic peptide values <400 pg/mL. Measurement of natriuretic peptides would avoid 67% of requested echocardiograms. CONCLUSIONS In a community population attended in primary care, the best cut-off point of N-terminal pro-B-type natriuretic peptide to rule out heart failure was 280 pg/mL. N-terminal pro-B-type natriuretic peptide measurement improve work-out diagnoses and could be cost-effectiveness.
Journal of Cellular Physiology | 2016
Esther Barreiro; Ester Puig‐Vilanova; Judith Marin‐Corral; Alba Chacon-Cabrera; Anna Salazar‐Degracia; Xavier Mateu; Luis Puente-Maestu; Elena García-Arumí; Antoni L. Andreu; Luis Molina
Patients with chronic heart failure (CHF) experience exercise intolerance, fatigue and muscle wasting, which negatively influence their survival. We hypothesized that treatment with either the antioxidant N‐acetyl cysteine (NAC) or the proteasome inhibitor bortezomib of rats with monocrotaline‐induced CHF may restore inspiratory and limb muscle mass, function, and structure through several molecular mechanisms involved in protein breakdown and metabolism in the diaphragm and gastrocnemius. In these muscles of CHF‐cachectic rats with and without treatment with NAC or bortezomib (N = 10/group) and non‐cachectic controls, proteolysis (tyrosine release, proteasome activities, ubiquitin‐proteasome markers), oxidative stress, inflammation, mitochondrial function, myosin, NF‐κB transcriptional activity, muscle structural abnormalities, and fiber morphometry were analyzed together with muscle and cardiac functions. In diaphragm and gastrocnemius of CHF‐cachectic rats, tyrosine release, proteasome activity, protein ubiquitination, atrogin‐1, MURF‐1, NF‐κB activity, oxidative stress, inflammation, and structural abnormalities were increased, while muscle and cardiac functions, myosin content, slow‐ and fast‐twitch fiber sizes, and mitochondrial activity were decreased. Concomitant treatment of CHF‐cachectic rats with NAC or bortezomib improved protein catabolism, oxidative stress, inflammation, muscle fiber sizes, function and damage, superoxide dismutase and myosin levels, mitochondrial function (complex I, gastrocnemius), cardiac function and decreased NF‐κB transcriptional activity in both muscles. Treatment of CHF‐cachectic animals with NAC or bortezomib attenuated the functional (heart, muscles), biological, and structural alterations in muscles. Nonetheless, future studies conducted in actual clinical settings are warranted in order to assess the potential beneficial effects and safety concerns of these pharmacological agents on muscle mass loss and wasting in CHF‐cachectic patients. J. Cell. Physiol. 231: 1495–1513, 2016.
Revista Espanola De Cardiologia | 2014
Núria Farré; Miquel Gómez; Luis Molina; Mercedes Cladellas; Mireia Ble; Cristina Roqueta; Maria Soledad Ascoeta; Josep Comin-Colet; Joan Vila; Jordi Bruguera
INTRODUCTION AND OBJECTIVES Our objective was to assess the prognostic value of NT-proBNP in patients with asymptomatic moderate/severe aortic stenosis and to validate an adapted Monin score using natriuretic peptide levels in our setting. METHODS Prospective study of 237 patients with degenerative asymptomatic moderate/severe aortic stenosis. NT-proBNP was determined in all patients, who were then followed up clinically. The adapted Monin score was defined as follows: (peak velocity [m/s]×2)+(logn NT-proBNP×1.5)(+1.5 if woman). A clinical event was defined as surgery, hospital admission due to angina, heart failure or syncope, or death. RESULTS A total of 51% were women, and the mean age was 74 years. Mean (SD) echocardiographic values were as follows: peak velocity 4.14 (0.87) m/s; mean gradient, 43.2 (16.0) mmHg; aortic valve area, 0.87 (0.72) cm(2), and aortic valve area index, 0.49 (0.14) cm(2)/m(2). The median NT-pro-BNP value was 490.0 [198.0-1312.0] pg/mL. There were 153 events during follow-up (median 18 months). The optimum NT-proBNP cut-point was 515 pg/mL, giving event-free survival rates at 1 and 2 years of 93% and 57%, respectively, in patients with NT-proBNP <515 pg/mL compared with 50% and 31% in those with NT-proBNP >515 pg/mL. Patients were divided into quartiles based on the Monin score. Event-free survival at 1 and 2 years was 87% and 79% in the first quartile, compared with 45% and 28% in the fourth quartile, respectively. CONCLUSIONS NT-proBNP determination provides prognostic information in patients with asymptomatic moderate/severe aortic stenosis. The adapted Monin score is useful in our setting and allows a more precise prognosis than does the use of NT-proBNP alone.
Archivos De Bronconeumologia | 2010
Mauricio Orozco-Levi; Ángel Gayete; Cristina Rodríguez; Alba Ramírez-Sarmiento; Raúl Méndez; Francesc Tous; Ivan Vollmer; Joaquim Gea; Luis Molina
a b s t r a c t The diaphragm is the principal respiratory muscle. Its special characteristics have made it difficult to design instruments capable of performing a non-invasive evaluation of its structure and function in humans. The present study was designed to evaluate the potential use of ultrasound as a non-invasive method to fulfil these objectives. Methods: The study consisted of three phases: (1) ultrasound study in autopsy samples (n=10) of a segment of the thoracic-abdominal wall, from the bottom to the parietal peritoneum (i.e., thoracic wall, diaphragm, pleura and peritoneum structures), (2) static ultrasound study of the previous structures and the diaphragm in healthy subjects (n=10) to standardised lung volumes; and (3) dynamic ultrasound study of the contraction-relaxation of the diaphragm in the same subjects, calculating its maximum velocity of relaxation (MVrdi, mm/sec) during a specific inspiratory resistance test. Results: The ultrasound enabled the pleural and peritoneal limits of the diaphragm to be identified, and quantify its thickness (Tdi), both ex-vivo and in-vivo, in all cases. The dynamic study of the Tdi showed a linear increase directly associated with the lung volume measurement, as well as a cyclical increase during inspiratory movements at rest. In the resistance test, the MVrdi was maximal with low loads and gradually decreased until reaching a minimum nadir (∆≈ -70% of the initial value) in claudication (fatigue). The MVrdi has a high precision in diagnosing claudication. Conclusions: Transthoracic ultrasound of the diaphragm is a non-invasive method that gives promising results in the structural and functional evaluation (i.e. fatigue risk) of that muscle. These findings are of pathophysiological interest and could be of use in the clinical care context.
Archivos De Bronconeumologia | 2010
Mauricio Orozco-Levi; Ángel Gayete; Cristina Rodríguez; Alba Ramírez-Sarmiento; Raúl Méndez; Francesc Tous; Ivan Vollmer; Joaquim Gea; Luis Molina
UNLABELLED The diaphragm is the principal respiratory muscle. Its special characteristics have made it difficult to design instruments capable of performing a non-invasive evaluation of its structure and function in humans. The present study was designed to evaluate the potential use of echography as a non-invasive method to fulfil these objectives. METHODS The study consisted of three phases: (1) echographic study in autopsy samples (n=10) of a segment of the thoracic-abdominal wall, from the bottom to the parietal peritoneum (i.e., thoracic wall, diaphragm, pleura and peritoneum structures), (2) static echographic study of the previous structures and the diaphragm in healthy subjects (n=10) to standardised lung volumes; and (3) dynamic echographic study of the contraction-relaxation of the diaphragm in the same subjects, calculating its maximum velocity of relaxation (MVrdi, mm/sec) during a specific inspiratory resistance test. RESULTS The echography enabled the pleural and peritoneal limits of the diaphragm to be identified, and quantitate its thickness (Tdi), both ex-vivo and in-vivo, in all cases. The dynamic study of the Tdi showed a linear increase directly associated with the lung volume measurement, as well as a cyclical increase during inspiratory movements at rest. In the resistance test, the MVrdi was maximal with low loads and gradually decrease until reaching a minimum nadir (Δ≈-70% of the initial value) in claudication (fatigue). The MVrdi has a high precision in diagnosing claudication. CONCLUSIONS Transthoracic echography of the diaphragm is a non-invasive method that gives promising results in the structural and functional evaluation (i.e. fatigue risk) of that muscle. These findings are of pathophysiological interest and could be of use in the clinical care context.
PLOS ONE | 2017
Luis Molina; Manuel Sarmiento; Judith Peñafiel; David Donaire; Judith Garcia-Aymerich; Miquel Gómez; Mireia Ble; Sonia Ruiz; Albert Francès; Helmut Schröder; Jaume Marrugat; Roberto Elosua
Objective To develop and validate a short questionnaire to estimate physical activity (PA) practice and sedentary behavior for the adult population. Methods The short questionnaire was developed using data from a cross-sectional population-based survey (n = 6352) that included the Minnesota leisure-time PA questionnaire. Activities that explained a significant proportion of the variability of population PA practice were identified. Validation of the short questionnaire included a cross-sectional component to assess validity with respect to the data collected by accelerometers and a longitudinal component to assess reliability and sensitivity to detect changes (n = 114, aged 35 to 74 years). Results Six types of activities that accounted for 87% of population variability in PA estimated with the Minnesota questionnaire were selected. The short questionnaire estimates energy expenditure in total PA and by intensity (light, moderate, vigorous), and includes 2 questions about sedentary behavior and a question about occupational PA. The short questionnaire showed high reliability, with intraclass correlation coefficients ranging between 0.79 to 0.95. The Spearman correlation coefficients between estimated energy expenditure obtained with the questionnaire and the number of steps detected by the accelerometer were as follows: 0.36 for total PA, 0.40 for moderate intensity, and 0.26 for vigorous intensity. The questionnaire was sensitive to detect changes in moderate and vigorous PA (correlation coefficients ranging from 0.26 to 0.34). Conclusion The REGICOR short questionnaire is reliable, valid, and sensitive to detect changes in moderate and vigorous PA. This questionnaire could be used in daily clinical practice and epidemiological studies.
Revista Espanola De Cardiologia | 2000
Enrique Pérez de la Sota; Randas J.V. Batista; José E. Rodríguez; José Cortina; Luis Maroto; María Jesús López Gude; Luis Molina; Juan José Rufilanchas
Introduccion y objetivos La escasez de donantes asi como la morbimortalidad asociada al trasplante han motivado el planteamiento de otras opciones quirurgicas para la miocardiopatia dilatada en fase terminal. Entre ellas se encuentra la ventriculectomia parcial izquierda, que implica la reduccion del diametro y la masa ventricular. Presentamos en este trabajo la experiencia inicial (no limitada a la alternativa al trasplante) y los resultados inmediatos de esta tecnica en nuestro centro. Metodos Hemos intervenido a 6 pacientes con miocardiopatia dilatada: cuatro de etiologia idiopatica y con motivos de exclusion para trasplante cardiaco y dos de origen valvular. Se practico reseccion de la pared lateral de ventriculo izquierdo entre los musculos papilares y cierre directo con sutura continua, asociandose anuloplastia mitral en 5 casos, tricuspidea en uno y sustitucion valvular aortica en los dos ultimos. Resultados Dos pacientes precisaron balon de contrapulsacion; uno fallecio por shock cardiogenico refractario y el otro a los 15 dias tras episodios de arritmia ventricular. Los estudios ecocardiograficos intraoperatorios pusieron de manifiesto una reduccion significativa del diametro diastolico (de 8,7 a 6,8 cm; p = 0,02) y de la insuficiencia mitral, con una mejoria en la fraccion de eyeccion (del 17 al 27%; p = 0,09) mantenidos en el ecocardiograma previo al alta. Conclusiones La tecnica es reproducible y adecuada como posibilidad terapeutica en la insuficiencia cardiaca en fase terminal. Quedan por precisar el grupo y tipo de paciente ideal, el manejo perioperatorio y el soporte a largo plazo.
American Journal of Cardiology | 2015
Miquel Gómez; Mireia Ble; Mercedes Cladellas; Luis Molina; Josep Comin-Colet; Cristina Enjuanes; Cristina Roqueta; Cristina Soler; Jordi Bruguera
The objective of the study is to investigate the impact of anemia (defined as hemoglobin concentration of <12 g/dl in women and 13 g/dl in men) on prognosis and to study the effect of recovery from anemia on echocardiographic and clinical parameters in patients with aortic stenosis (AS). This was a prospective study in 315 patients with moderate or severe AS. Patients with anemia received oral iron (ferrous sulfate with mucoproteose, 160 mg iron/day) and erythropoietin, if needed, or intravenous iron, if necessary. The following tests were performed before and after normalization of hemoglobin values: echocardiogram, 6-minute walk test, N-terminal B-type natriuretic peptide, and measures of depression, cognitive impairment, and dependence. Patient mean age was 74 years (SD 9). Mean follow-up was 25 months (SD 8). Anemia prevalence in the overall group was 22% (n = 70). Patients who are anemic had a higher rate of complications at follow-up (mortality, hospital admission, or need for valve procedure; 80% vs 62%, p = 0.009). In total, 89% of patients recovered from anemia, with a mean time to recovery of 4.6 weeks (SD 1.4). Improvements were observed on echocardiographic parameters of peak velocity (4.1 to 3.7 m/s, p = 0.02) and mean gradient (44 to 35 mm Hg, p = 0.02). Performance on the 6-minute walk test improved from 235 to 303 m (p <0.001). Median N-terminal B-type natriuretic peptide value decreased from 612 to 189 pg/dl (p <0.001). In conclusion, patients with AS and anemia have a worse prognosis than those without anemia. Resolution of anemia is associated with improvements in echocardiographic parameters and functional status, suggesting that treatment of iron deficiency is a relevant option in the management of patients with AS, particularly in nonoperable cases.